[Evaluation of Abbott CD 3500 in severe leukopenia].

M Fournier, A Gireau, B Boniface, C Ghevaert, P Lepelley, M Zandecki, J Goudemand, A Cosson
{"title":"[Evaluation of Abbott CD 3500 in severe leukopenia].","authors":"M Fournier,&nbsp;A Gireau,&nbsp;B Boniface,&nbsp;C Ghevaert,&nbsp;P Lepelley,&nbsp;M Zandecki,&nbsp;J Goudemand,&nbsp;A Cosson","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Leucopenia patient follow-up remains, in terms of laboratory turnaround, a heavy workload due to the leucoconcentrations necessary for evaluating leucocytic formulas. We tested the CD 3500 with the objective of defining its' analytical performances and routine practice. 101 leucopenia samples (< 2.10(9)/l) procured from the onco-hematology department (adults and children) were studied during a 1 month period. The leucocytic formula obtained after leuconcentrations was our reference. The alarm sensitivity, as a whole, was of 97% for a 15.5% specificity. The correlation coefficients (Cell-Dyn/microscope) for polynuclears, lymphocytes and monocytes were respectively 0.889, 0.925 and 0.926. The correlation coefficients observed in both following subgroups: < or = 0.5.10(9)/l and > 0.5.10(9)/l were superposable. In 95% of the cases, the numeric value difference between the two methods attained a maximum of 21% for all neutrophils and lymphocytes and 13% for the monocytes. There was an excellent concordance between both methods for eosinophilia and basophils with confidence intervals of +/-8.8% and +/-2.2%. In practice, we feel that the use of a CD 3500 in post chemotherapy leucopenia, is perfectly adaptable and appreciated for leucocytic formulas, as well as a good exit for aplasia.</p>","PeriodicalId":19366,"journal":{"name":"Nouvelle revue francaise d'hematologie","volume":"36 Suppl 2 ","pages":"S117-21"},"PeriodicalIF":0.0000,"publicationDate":"1994-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nouvelle revue francaise d'hematologie","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Leucopenia patient follow-up remains, in terms of laboratory turnaround, a heavy workload due to the leucoconcentrations necessary for evaluating leucocytic formulas. We tested the CD 3500 with the objective of defining its' analytical performances and routine practice. 101 leucopenia samples (< 2.10(9)/l) procured from the onco-hematology department (adults and children) were studied during a 1 month period. The leucocytic formula obtained after leuconcentrations was our reference. The alarm sensitivity, as a whole, was of 97% for a 15.5% specificity. The correlation coefficients (Cell-Dyn/microscope) for polynuclears, lymphocytes and monocytes were respectively 0.889, 0.925 and 0.926. The correlation coefficients observed in both following subgroups: < or = 0.5.10(9)/l and > 0.5.10(9)/l were superposable. In 95% of the cases, the numeric value difference between the two methods attained a maximum of 21% for all neutrophils and lymphocytes and 13% for the monocytes. There was an excellent concordance between both methods for eosinophilia and basophils with confidence intervals of +/-8.8% and +/-2.2%. In practice, we feel that the use of a CD 3500 in post chemotherapy leucopenia, is perfectly adaptable and appreciated for leucocytic formulas, as well as a good exit for aplasia.

[雅培cd3500治疗严重白细胞减少症的疗效评价]。
白细胞患者随访,在实验室周转方面,由于评估白细胞配方所需的白细胞浓度,工作量很大。我们测试了cd3500,目的是确定其分析性能和常规操作。从肿瘤血液科(成人和儿童)获得的101份白细胞减少样本(< 2.10(9)/l)进行了为期1个月的研究。白细胞浓缩后得到的白细胞配方作为我们的参考。整体而言,报警灵敏度为97%,特异度为15.5%。多核细胞、淋巴细胞和单核细胞的相关系数(Cell-Dyn/显微镜)分别为0.889、0.925和0.926。在<或= 0.5.10(9)/l和> 0.5.10(9)/l两个亚组中观察到的相关系数是重叠的。在95%的病例中,两种方法之间的数值差异在所有中性粒细胞和淋巴细胞中达到最大21%,在单核细胞中达到13%。两种方法测定嗜酸性粒细胞和嗜碱性粒细胞的置信区间分别为+/-8.8%和+/-2.2%,具有很好的一致性。在实践中,我们认为在化疗后白细胞减少中使用cd3500是完全适应和赞赏的白细胞配方,以及对发育不全的良好退出。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信